Xiangxue Pharmaceutical Co.,Ltd. (SHE:300147)
China · Delayed Price · Currency is CNY 6.28
+0.03 (0.48%)
Sep 2, 2026, 3:04 PM CST
Xiangxue Pharmaceutical Market Cap
Xiangxue Pharmaceutical has a market cap or net worth of 4.13 billion as of September 1, 2026. Its market cap has decreased by -45.46% in one year.
Market Cap
4.13B
Enterprise Value
5.78B
Revenue
1.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
6.28
ChartMarket Cap Chart
Since December 15, 2010, Xiangxue Pharmaceutical's market cap has decreased from 4.81B to 4.13B, a decrease of -14.06%. That is a compound annual growth rate of -0.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 4.13B | -31.32% |
| Dec 31, 2025 | 6.02B | -6.86% |
| Dec 31, 2024 | 6.46B | 89.71% |
| Dec 29, 2023 | 3.41B | -14.02% |
| Dec 30, 2022 | 3.96B | -24.79% |
| Dec 31, 2021 | 5.27B | -9.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Konruns Pharmaceutical | 4.84B |
| ChemPartner PharmaTech | 4.82B |
| Wuhan Hvsen Biotechnology | 4.66B |
| Zhejiang Wecome Pharmaceutical Company | 4.55B |
| Shanghai Obio Technology (Group) Corp. | 4.32B |
| Kexing Biopharm | 4.27B |
| Hefei Lifeon Pharmaceutical | 4.26B |
| Anhui Huaheng Biotechnology | 4.23B |